Brief Communication Antidepressants and the Risk of Breast Cancer

Sharpe and others published a case–control study reporting that the heavy use of certain tricyclic antidepressants (TCAs) is associated with an increased risk of breast cancer that fol-lows a 10-year lag from the time of antidepressant use (1). The tricyclic agents implicated in the study are amoxapine, clomi